본문 바로가기
KERD
논문KCI 등재

Microbiology and Antimicrobial Therapy for Diabetic Foot Infections

권기태|David G. Armstrong
대한감염학회 (The Korean Society Of Infectious Diseases)|2018.03|Infection and Chemotherapy|제50권 제1호|pp. 11-20

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

AntibioticsDiabetic footInfectionsMicrobiology
주제분류내과학

초록

In addition to being the prime factor associated with amputation, diabetic foot infections (DFIs) are associated with major morbidity, increasing mortality, and reduced quality of life. The choice of appropriate antibiotics is very important in order to reduce treatment failure, antimicrobial resistance, adverse events, and costs. We reviewed articles on microbiology and antimicrobial therapy and discuss antibiotic selection in Korean patients with DFIs. Similar to Western countries, Staphylococcus aureus is the most common pathogen, with Streptococcus, Enterococcus, Enterobacteriaceae and Pseudomonas also prevalent in Korea. It is recommended that antibiotics are not prescribed for clinically uninfected wounds and that empirical antibiotics be selected based on the clinical features, disease severity, and local antimicrobial resistance patterns. Narrow-spectrum oral antibiotics can be administered for mild infections and broad-spectrum parenteral antibiotics should be administered for some moderate and severe infections. In cases with risk factors for methicillin-resistant S. aureus or Pseudomonas, empirical antibiotics to cover each pathogen should be considered. The Health Insurance Review and Assessment Service standards should also be considered when choosing empirical antibiotics. In Korea, nationwide studies need to be conducted and DFI guidelines should be developed.

Abstract

In addition to being the prime factor associated with amputation, diabetic foot infections (DFIs) are associated with major morbidity, increasing mortality, and reduced quality of life. The choice of appropriate antibiotics is very important in order to reduce treatment failure, antimicrobial resistance, adverse events, and costs. We reviewed articles on microbiology and antimicrobial therapy and discuss antibiotic selection in Korean patients with DFIs. Similar to Western countries, Staphylococcus aureus is the most common pathogen, with Streptococcus, Enterococcus, Enterobacteriaceae and Pseudomonas also prevalent in Korea. It is recommended that antibiotics are not prescribed for clinically uninfected wounds and that empirical antibiotics be selected based on the clinical features, disease severity, and local antimicrobial resistance patterns. Narrow-spectrum oral antibiotics can be administered for mild infections and broad-spectrum parenteral antibiotics should be administered for some moderate and severe infections. In cases with risk factors for methicillin-resistant S. aureus or Pseudomonas, empirical antibiotics to cover each pathogen should be considered. The Health Insurance Review and Assessment Service standards should also be considered when choosing empirical antibiotics. In Korea, nationwide studies need to be conducted and DFI guidelines should be developed.

참고문헌 (66)

  1. Armstrong DG, "Diabetic foot ulcers and their recurrence", N Engl J Med, 376, pp.2367~2375 (2017)[DOI]
  2. Raspovic KM, "Self-reported quality of life and diabetic foot infections", J Foot Ankle Surg, 53, pp.716~719 (2014)[DOI]
  3. "Diabetes fact sheet in Korea 2016"[URL]
  4. 배재익, "국내 당뇨발의 유병률과 치료현황 분석", 대한영상의학회지, 74(3), pp.169~176 (2016), 대한영상의학회[DOI]
  5. 정춘희, "우리나라 당뇨병성 족부질환의 현황: 건강보험자료 분석결과", Diabetes and Metabolism Journal, 30(5), pp.372~376 (2006), 대한당뇨병학회
  6. Lipsky BA, "2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections", Clin Infect Dis, 54, pp.e132~e173 (2012)[DOI]
  7. Peters EJ, "Diagnosis and management of infection in the diabetic foot", Med Clin North Am, 97, pp.911~946 (2013)[DOI]
  8. Nather A, "Epidemiology of diabetic foot problems and predictive factors for limb loss", J Diabetes Complications, 22, pp.77~82 (2008)[DOI]
  9. Uckay I, "Diabetic foot infections: state-of-the-art", Diabetes Obes Metab, 16, pp.305~316 (2014)[DOI]
  10. Miyan Z, "Microbiological pattern of diabetic foot infections at a tertiary care center in a developing country", J Pak Med Assoc, 67, pp.665~669 (2017)
  11. Lipsky BA, "IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes", Diabetes Metab Res Rev, 32(Suppl 1), pp.45~74 (2016)[DOI]
  12. Korean Society for Diabetic Foot, "Korean guideline for management of diabetic foot", pp.49~66 (2014), Koonja Press
  13. Lipsky BA, "Outpatient management of uncomplicated lower-extremity infections in diabetic patients", Arch Intern Med, 150, pp.790~797 (1990)[DOI]
  14. Young H, "How do preoperative antibiotics affect culture yield in diabetic foot infections?", Open Forum Infect Dis, 4, pp.ofx016~ (2017)
  15. Chakraborti C, "Sensitivity of superficial cultures in lower extremity wounds", J Hosp Med, 5, pp.415~420 (2010)[DOI]
  16. Pellizzer G, "Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection", Diabet Med, 18, pp.822~827 (2001)[DOI]
  17. Nelson EA, "Concordance in diabetic foot ulceration: a cross-sectional study of agreement between wound swabbing and tissue sampling in infected ulcers", Health Technol Assess, 20, pp.1~176 (2016)
  18. 이성미, "만성 당뇨발에서 표재조직 및 심부조직 세균배양검사의 비교", Archives of Plastic Surgery, 37(1), pp.1~6 (2010), 대한성형외과학회
  19. Senneville E, "Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures", Clin Infect Dis, 42, pp.57~62 (2006)[DOI]
  20. Embil JM, "Microbiological evaluation of diabetic foot osteomyelitis", Clin Infect Dis, 42, pp.63~65 (2006)[DOI]
  21. 이성미, "골조직 병변이 있는 당뇨발 궤양에서 표재조직 및 골조직 세균배양 검사의 비교", Archives of Plastic Surgery, 37(4), pp.335~339 (2010), 대한성형외과학회
  22. Sotto A, "Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers", Diabetologia, 53, pp.2249~2255 (2010)[DOI]
  23. Lipsky BA, "Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream", Clin Infect Dis, 47, pp.1537~1545 (2008)[DOI]
  24. Lipsky BA, "The diabetic foot. Soft tissue and bone infection", Infect Dis Clin North Am, 4, pp.409~432 (1990)
  25. Saseedharan S, "Epidemiology of diabetic foot infections in a reference tertiary hospital in India", Braz J Microbiol (2017)
  26. Hatipoglu M, "The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey", Eur J Clin Microbiol Infect Dis, 33, pp.871~878 (2014)[DOI]
  27. Ramakant P, "Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?", Diabetologia, 54, pp.58~64 (2011)[DOI]
  28. Song JY, "Antimicrobial therapy in diabetic foot infections", J Korean Diabetes, 12, pp.83~87 (2011)[DOI]
  29. 최상록, "당뇨족 궤양의 세균 역학과 항생제 감수성", Archives of Plastic Surgery, 33(3), pp.330~334 (2006), 대한성형외과학회
  30. 서유빈, "감염성 당뇨 족부 궤양: 심부 조직 배양 검사 결과에 기초한 원인균 분석", Infection and Chemotherapy, 39(5), pp.237~242 (2007), 대한감염학회
  31. 이두형, "당뇨병성 족부 감염 환자의 초기 선택 항생제 효율성", 대한족부족관절학회지, 13(2), pp.146~149 (2009), 대한족부족관절학회
  32. 박세진, "감염된 당뇨병성 족부 병변의 균주 조사 및 항생제 선택", 대한족부족관절학회지, 13(2), pp.150~155 (2009), 대한족부족관절학회
  33. Son ST, "The microbiology of diabetic foot infections in Korea", J Wound Management Res, 13, pp.8~12 (2017)[DOI]
  34. Charles PG, "The role of anaerobes in diabetic foot infections", Anaerobe, 34, pp.8~13 (2015)[DOI]
  35. Lavigne JP, "New molecular techniques to study the skin microbiota of diabetic foot ulcers", Adv Wound Care (New Rochelle), 4, pp.38~49 (2015)[DOI]
  36. Stappers MH, "Bacteroides fragilis in biopsies of patients with major abscesses and diabetic foot infections: direct molecular versus culture-based detection", Diagn Microbiol Infect Dis, 85, pp.263~265 (2016)[DOI]
  37. Malone M, "Can molecular DNA-based techniques unravel the truth about diabetic foot infections?", Diabetes Metab Res Rev, 33, pp.e2834~ (2017)[DOI]
  38. Eleftheriadou I, "Methicillin-resistant Staphylococcus aureus in diabetic foot infections", Drugs, 70, pp.1785~1797 (2010)[DOI]
  39. Lee JS, "Risk factors of methicillin-resistant Staphylococcus aureus and Pseudomonas infection in diabetic foot ulcers in Korea", J Wound Management Res, 13, pp.29~34 (2017)[DOI]
  40. Rolain JM, "Worldwide decrease in methicillin-resistant Staphylococcus aureus: do we understand something?", Clin Microbiol Infect, 21, pp.515~517 (2015)[DOI]
  41. Dantes R, "Emerging Infections Program- Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011", JAMA Intern Med, 173, pp.1970~1978 (2013)
  42. Landrum ML, "Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010", JAMA, 308, pp.50~59 (2012)
  43. Fatkenheuer G, "Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence", Lancet, 385, pp.1146~1149 (2015)[DOI]
  44. Zenelaj B, "Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens?", Int J Low Extrem Wounds, 13, pp.263~272 (2014)[DOI]
  45. Reveles KR, "Epidemiology of methicillin-resistant Staphylococcus aureus diabetic foot infections in a large academic hospital: implications for antimicrobial stewardship", PLoS One, 11, pp.e0161658~ (2016)[DOI]
  46. 곽이경, "단독과 연조직염의 임상적 특성과 원인균에 관한 연구", Infection and Chemotherapy, 44(2), pp.45~50 (2012), 대한감염학회[DOI]
  47. 최성호, "지역사회 획득 괴사성 근막염의 임상적 특성과 원인균에 관한 연구", Infection and Chemotherapy, 44(3), pp.180~184 (2012), 대한감염학회[DOI]
  48. "Int J Antimicrob Agents", 2017, S75~, 10.1016[DOI]
  49. "Int J Antimicrob Agents", 2017, S136~
  50. Rastogi A, "The microbiology of diabetic foot infections in patients recently treated with antibiotic therapy: a prospective study from India", J Diabetes Complications, 31, pp.407~412 (2017)[DOI]
  51. Hatipoglu M, "Causative pathogens and antibiotic resistance in diabetic foot infections: a prospective multi-center study", J Diabetes Complications, 30, pp.910~916 (2016)[DOI]
  52. Anvarinejad M, "Isolation and antibiotic susceptibility of the microorganisms isolated from diabetic foot infections in Nemazee Hospital, Southern Iran", J Pathog, 2015, pp.328796~ (2015)
  53. Lavery LA, "Validation of the Infectious Diseases Society of America’s diabetic foot infection classification system", Clin Infect, 44, pp.562~565 (2007)[DOI]
  54. Lipsky BA, "The value of a wound score for diabetic foot infections in predicting treatment outcome: a prospective analysis from the SIDESTEP trial", Wound Repair Regen, 17, pp.671~677 (2009)[DOI]
  55. Aragon-Sanchez J, "Seminar review: a review of the basis of surgical treatment of diabetic foot infections", Int J Low Extrem Wounds, 10, pp.33~65 (2011)[DOI]
  56. Williams DT, "Diagnosing foot infection in diabetes", Clin Infect Dis, 39(Suppl 2), pp.S83~S86 (2004)[DOI]
  57. Edmonds M, "Double trouble: infection and ischemia in the diabetic foot", Int J Low Extrem Wounds, 8, pp.62~63 (2009)[DOI]
  58. Richard JL, "Diabetes and foot infection: more than double trouble", Diabetes Metab Res Rev, 28(Suppl 1), pp.46~53 (2012)[DOI]
  59. Abbas M, "In diabetic foot infections antibiotics are to treat infection, not to heal wounds", Expert Opin Pharmacother, 16, pp.821~832 (2015)[DOI]
  60. Gardner SE, "Clinical signs of infection in diabetic foot ulcers with high microbial load", Biol Res Nurs, 11, pp.119~128 (2009)[DOI]
  61. Selva Olid A, "Systemic antibiotics for treating diabetic foot infections", Cochrane Database Syst Rev (2015)
  62. 이신원, "Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital", The Korean Journal of Internal Medicine, 29(1), pp.49~56 (2014), 대한내과학회[DOI]
  63. 곽이경, "Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection", Infection and Chemotherapy, 49(4), pp.301~325 (2017), 대한감염학회
  64. "Portal service for medical institution"[URL]
  65. Uckay I, "Diabetic foot infections: what have we learned in the last 30 years?", Int J Infect Dis, 40, pp.81~91 (2015)[DOI]
  66. Uckay I, "Foreign body infections due to Staphylococcus epidermidis", Ann Med, 41, pp.109~119 (2009)[DOI]

관련 논문AI추천

감염된 당뇨병성 족부 병변의 균주 조사 및 항생제 선택김유진, 박세진, 신헌규, 윤지웅, 임종준, 정화재대한족부족관절학회 · 대한족부족관절학회지2009 · 제13권 제2호당뇨병성 족부 감염 환자의 초기 선택 항생제 효율성박민정, 이두형, 한승환대한족부족관절학회 · 대한족부족관절학회지2009 · 제13권 제2호당뇨발 절단에 있어 원인 감염균과 치료 결과와의 관계왕립, 김기웅, 김성수, 김철홍, 김현준, 이규열, 이명진대한족부족관절학회 · 대한족부족관절학회지2013 · 제17권 제3호A Systematic Review of Randomized Controlled Trials of Antibiotic Use in Diabetic Foot Ulcer Infections: Focus on Clinical CurePratama Vincent, Risni Hindun Wilda, Sauriasari Rani, Yunir Em대한감염학회 · Infection and Chemotherapy2022 · 제54권 제1호단일 3차 의료기관에 내원한 당뇨병성 족부병변 환자의 창상 배양검사를 통한 세균 검출 현황이명진, 이상윤, 이승엽, 정성윤대한족부족관절학회 · 대한족부족관절학회지2021 · 제25권 제2호감염성 당뇨 족부 궤양: 심부 조직 배양 검사 결과에 기초한 원인균 분석김우주, 노지윤, 서유빈, 송준영, 이재갑, 정희진, 한승규, 허중연대한감염학회 · Infection and Chemotherapy2007 · 제39권 제5호

이 간행물의 다른 논문 (12건)

Albendazole and Praziquantel: Review and Safety Monitoring in Korea홍성태pp. 1-10Epidemiology, Microbiological and Clinical Features, Treatment, and Outcomes of Infective Endocarditis in Crete, GreeceDiamantis P. Kofteridis, George Samonis, Panteleimon E. Papakonstantinou, Angeliki M. Andrianaki, Maria Christofaki, Dimitra Dimopoulou, John Papadakis, Achilleas Gikaspp. 21-28Genotypic Diversity of Multidrug Resistant Shigella species from IranHossein Hosseini Nave, Younes Khalili, Sajjad Zamanlou, Mohammad Ahangarzadeh Rezaee, Mohammad Aghazadeh, Reza Ghotasloupp. 29-37Investigation of Scarlet Fever Outbreak in a Kindergarten천병철, 유석현pp. 38-42Outcome in Patients with Fever of Unknown Origin whose 18Fluoro-Deoxyglucose Positron Emission Tomography/Computerized Tomography Finding is Non-Diagnostic황재필, 박정미, 박진, 정혜민, 전찬홍, 추은주, 김탁pp. 43-47
원문 보기